<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02298413</url>
  </required_header>
  <id_info>
    <org_study_id>RAI-Registro Absorb Italiano</org_study_id>
    <nct_id>NCT02298413</nct_id>
  </id_info>
  <brief_title>Italian Absorb Registry</brief_title>
  <acronym>BVS-RAI</acronym>
  <official_title>Clinical Study on Absorb Polylactic, Reabsorbable Coronary Scaffold (RAI)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ospedale Santa Croce-Carle Cuneo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fatebenefratelli and Ophthalmic Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bolognini Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ospedale Regionale di Aosta</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ospedali Riuniti di Ancona</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>S. Giacomo Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda U.L.S.S n.9 Ospedale di Treviso Ca Foncello</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ospedale San Bortolo di Vicenza</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Ospedaliera Brotzu</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>San Giuseppe Moscati Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Sanitaria Locale USL 13 Ospedale Mazzoni di Ascoli Piceno</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>S. Andrea Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ospedale Monaldi di Napoli</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Ospedaliera di Padova</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ospedale della Misericordia di Grosseto</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ospedale Santa Corona di Pietra Ligure</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Istituto di Ricerche Farmacologiche Mario Negri Milano</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ospedale Santa Croce-Carle Cuneo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators aim at evaluating the long-term (5-year) clinical outcome following Absorb
      BVS implantation in a real world, all-comers population of consecutive patients, as treated
      according to the indications, techniques and protocols used in the participating
      institutions.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Long-term data after implantation of coronary BVS is scarce, especially in subgroups of
      patients with diabetes or chronic kidney disease, and in those with complex coronary lesions
      and/or multivessel disease.

      Although the use of BVS is very promising in younger patients with one or more of the above
      characteristics, evidence of benefit is not available.

      The BVS-RAI Registry is a spontaneous initiative of a group of Italian interventional
      cardiologists who are interested in assessing the results of their interventional practice
      with BVS, by sharing data.

      The BVS-RAI Registry has been created in joint-venture with Centro di Ricerche Farmacologiche
      e Biomediche &quot;Mario Negri Sud&quot;, and is not recipient of funding or benefits originating from
      the BVS manufacturer or seller. BVS devices are regularly purchased by the participating
      centres.

      Each participating centre is willing to input data of all consecutive patients treated with
      BVS, with a minimum of 50, and to report on follow-up for at least 5 years. Patient
      recruitment is not directed per protocol, nor is it rewarded. Patients who give informed
      consent are included in the BVS-RAI Registry after BVS implant has been performed following
      the indications, techniques and protocols used in each of the participating institutions.

      Baseline patient clinical data, with special attention to biochemistry and drug treatment in
      patients with diabetes and CKD, as well as angiographic and intravascular imaging data are
      entered into a web-based Case Report Form.

      Follow-up data from outpatient visits or phone interviews, subsequent admissions and coronary
      angiograms following the protocols being used in each of the participating institutions are
      prospectively collected and entered into the database.

      All data in the CRF is visible to all registered participants at all times. Endpoints are:
      target lesion and target vessel failure, BVS thrombosis, new revascularisation, myocardial
      infarction and death. Documentation of those events is required for adjudication by an
      independent committee.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">May 2021</completion_date>
  <primary_completion_date type="Anticipated">November 2016</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>Scaffold thrombosis</measure>
    <time_frame>1 year</time_frame>
    <description>acute, subacute, late and very late</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Target lesion revascularization</measure>
    <time_frame>1 year</time_frame>
    <description>ischemia or angiographic-driven</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>MACE</measure>
    <time_frame>5 year</time_frame>
    <description>Cardiac death, TLR, myocardial infarction</description>
  </secondary_outcome>
  <enrollment type="Actual">1520</enrollment>
  <condition>Coronary Artery Disease</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PCI with Absorb scaffold</intervention_name>
    <description>Implantation of biovascular scaffold during PCI</description>
    <other_name>biovascular resorbable scaffold</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        This is an all-comers study, and includes all consecutive patients who have been treated
        with 1 or more BVS in the study time lapse in each participating centre
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Successful implantation of 1 or more coronary BVS

          -  Age &lt;75 years

          -  Patient's informed consent

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alfonso Ielasi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>AO Seriate</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bernardo Cortese, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>AO Fatebenefratelli</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Donatella Corrado, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Istituto di Ricerche Farmacologiche Mario Negri Milano</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>SSD Emodinamica Dip Cardiovasc ASO S.Croce</name>
      <address>
        <city>Cuneo</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 15, 2014</study_first_submitted>
  <study_first_submitted_qc>November 19, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 24, 2014</study_first_posted>
  <last_update_submitted>February 3, 2016</last_update_submitted>
  <last_update_submitted_qc>February 3, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 4, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ospedale Santa Croce-Carle Cuneo</investigator_affiliation>
    <investigator_full_name>Dr Giuseppe Steffenino</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

